Methylation Sciences
Latest round
- Series A
Last raised
- Sep 2011
Total raised
- $19M
Investors
- 3
About Methylation Sciences
Methylation Sciences Inc.Founded in 2007, Methylation Sciences Inc. is based in Burnaby, Canada, and is dedicated to the study of DNA methylation's impact on health. The company has undergone strategic pivots but maintains its focus on developing innovative therapeutic solutions.Methylation Sciences Inc. specializes in developing therapeutic solutions targeted at understanding and manipulating DNA methylation processes.Methylation Sciences Inc. generates revenue primarily through its research and development initiatives, focusing on the creation of therapies derived from its findings in DNA methylation.Methylation Sciences Inc. plans to enhance its research portfolio by launching new therapeutic products focusing on DNA methylation mechanisms in the coming years. The firm aims to expand its market presence, specifically targeting North American and European markets by 2025.
Who invested in Methylation Sciences
3 investors across 1 round
See all investors in Methylation Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 29, 2011
Amount
$19M
Investors
Questions about Methylation Sciences
Who invested in Methylation Sciences?
Methylation Sciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Methylation Sciences raised?
Methylation Sciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Methylation Sciences last raise money?
Methylation Sciences's most recent round on record is a Series A, in Sep 2011.
What does Methylation Sciences do?
Methylation Sciences is a biotechnology company.
Where is Methylation Sciences headquartered?
Methylation Sciences is headquartered in Burnaby, Canada.
Which VCs invest in companies like Methylation Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Methylation Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Methylation Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.